Newstral
Article
The Hindu on 2021-07-24 10:30
Brazil suspends Bharat Biotech's Covaxin clinical trials
Related news
- Brazil suspends Bharat Biotech's Covaxin order for 20m dosesThe Times of India
- Covaxin starts clinical trials, 375 people enrolledThe Times of India
- DCGI approves Bharat Biotech's intranasal booster dose trialsThe Times of India
- Covid vaccine: Bharat Biotech starts clinical trialsThe Times of India
- Bharat Biotech terminates Covaxin pact with Brazil partnersThe Times of India
- Covaxin Phase 2&3 trials to resume in US after USFDA lifts clinical holdThe Times of India
- Coronavirus | WHO suspends clinical trials of hydroxychloroquine over safety concernsThe Hindu
- Brazil suspends clinical trials for China’s coronavirus vaccineisraelnationalnews.com
- Bharat Biotech begins clinical trials of more effective TB vaccine in IndiaThe Times of India
- Covaxin safe for kids: Bharat BiotechThe Times of India
- Bharat Biotech clarifies on COVAXIN usageThe Hindu
- Bharat Biotech's nasal vaccine will be used as booster doseThe Times of India
- Can Bharat Biotech's nasal vaccine be a gamechanger?The Times of India
- Coronavirus | After SII, Bharat Biotech seeks DCGI approval for CovaxinThe Hindu
- Covaxin: Human clinical trials of vaccine beginThe Times of India
- Vaccine: Covaxin trials done on 375 peopleThe Times of India
- DCGI nod for Covaxin human trialsThe Hindu
- Coronavirus | Covaxin trial participants could test positive, says Bharat BiotechThe Hindu
- Slowing down Covaxin output across plants: Bharat BiotechThe Times of India
- 'Bharat Biotech yet to apply for Covaxin approval by Canada'The Times of India